Please click the link below for our views on technical, fundamental and economic developments driving the S&P 500 Healthcare Sector as we start April. Healthcare Sector April Outlook
ETFSector.com April Outlook: Healthcare Sector Read More »
Finally, some signs of life from a sector that was moribund in 2024
Healthcare Sector February 2025 Outlook—Signs of a Turnaround Read More »
Inspira is getting ready to start production in reaction to the spread of a respiratory virus in China.
Wedbush reaffirmed an “outperform” rating and established a $47.00 price target for shares of Scholar Rock in a recent research report.
Scholar Rock was given an “Outperform” rating by Wedbush. Read More »
Some individuals searching for employment in 2025 may be seeking remote job opportunities, according to a new report by FlexJobs that highlights the companies with the highest number of positions available with remote work options.
Representative Virginia Foxx purchased shares of Amgen Inc. in a recent filing disclosed on January 06th, revealing the purchase of a specific amount.
Rep. Virginia Foxx purchases stock in Amgen Inc. (NASDAQ:AMGN). Read More »
Read More: https://www.tipranks.com/news/blurbs/btig-sticks-to-their-buy-rating-for-globus-medical-gmed-2?utm_source=alphanewsstream.com&utm_medium=referral
BTIG maintains their recommendation to buy Globus Medical (GMED). Read More »
Read More: https://www.tipranks.com/news/the-fly/boston-scientific-bolt-medical-acquisition-checks-right-boxes-jpmorgan-says?utm_source=alphanewsstream.com&utm_medium=referral
Read More: https://www.benzinga.com/insights/news/25/01/42864060/heres-how-much-1000-invested-in-abbvie-5-years-ago-would-be-worth-today?utm_source=TechInvestorNews&utm_campaign=partner_feed&utm_medium=partner_feed&utm_content=site
Here is the current value of $1000 invested in AbbVie 5 years ago. Read More »
Stay updated with the latests analysis and insights fromm etfsector.com
